Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 3
A Phase 3, Randomized, Double-blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat.
A phase 3, randomized, double-blinded, placebo-controlled study to evaluate the efficacy, safety, and tolerability of CBL-514 injection for reducing abdominal …
Subcutaneous Fat
Estimated
~$10 – $8,750
Caliway Biopharmaceuticals Co., Ltd.NCT07140939
Phase 3
A Phase 3, Randomized, Double-blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat.
A phase 3, randomized, double-blinded, placebo-controlled study to evaluate the efficacy, safety, and tolerability of CBL-514 injection for reducing abdominal …
Subcutaneous Fat
Estimated
~$10 – $8,750
Caliway Biopharmaceuticals Co., Ltd.NCT07526974